Press Coverage Year None20202019201820172016 Date Title Jun 18, 2020 Dicerna nabs speedy review voucher for leading RNAi drug Source FierceBiotech Apr 7, 2020 Alnylam and Dicerna to develop liver disease therapies Source Pharmaceutical Technology Apr 6, 2020 Former gene-silencing rivals bury the hatchet with new partnership Source Boston Business Journal Apr 6, 2020 Alnylam and Dicerna are pals now, which could spell trouble for Arrowhead Source BioPharma Dive Apr 6, 2020 Alnylam and Dicerna, onetime rivals, announce a ceasefire Source STAT Apr 6, 2020 Chasing Arrowhead, onetime rivals Alnylam and Dicerna unite on liver disease Source FierceBiotech Apr 6, 2020 After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration Source Endpoints Jan 11, 2020 RNAi: Advancing the Field of Biology Source PharmaVOICE By Denise Myshko
Press Coverage Year None20202019201820172016 Date Title Jun 18, 2020 Dicerna nabs speedy review voucher for leading RNAi drug Source FierceBiotech Apr 7, 2020 Alnylam and Dicerna to develop liver disease therapies Source Pharmaceutical Technology Apr 6, 2020 Former gene-silencing rivals bury the hatchet with new partnership Source Boston Business Journal Apr 6, 2020 Alnylam and Dicerna are pals now, which could spell trouble for Arrowhead Source BioPharma Dive Apr 6, 2020 Alnylam and Dicerna, onetime rivals, announce a ceasefire Source STAT Apr 6, 2020 Chasing Arrowhead, onetime rivals Alnylam and Dicerna unite on liver disease Source FierceBiotech Apr 6, 2020 After putting aside a bitter legal feud, Alnylam and Dicerna chiefs make nice with an RNAi collaboration Source Endpoints Jan 11, 2020 RNAi: Advancing the Field of Biology Source PharmaVOICE By Denise Myshko
